DEUTSCHE BANK AG\

Bank

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in VTGN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,760

-$5,454 QoQ

Shares Held

12,000

+173.2% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 48 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. VTGN ranks #292 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,760	12,000	+173.2%	Shares	Defined	2026-08-07
2023-06-30	$8,214	4,393	-98.3%	Shares	Defined	2023-08-14
2023-03-31	$30,243	252,033	+188.0%	Shares	Defined	2023-05-15
2022-12-31	$8,749	87,506	-73.4%	Shares	Defined	2023-02-13
2022-09-30	$49,380	329,205	+231.8%	Shares	Defined	2022-11-14
2022-06-30	$87,303	99,209	-11.8%	Shares	Defined	2022-08-11
2022-03-31	$139,511	112,510	-10.0%	Shares	Defined	2022-05-13
2021-12-31	$243,790	125,021	+5.2%	Shares	Defined	2022-02-16
2021-09-30	$325,497	118,795	-36.3%	Shares	Defined	2021-11-04
2021-06-30	$587,904	186,637	—	Shares	Defined	2021-08-11
No filing history on record for this holder in this stock.